Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Current Ratio: 1.98

Is Zimmer Biomet Holdings, Inc.’s current ratio high or low?

Zimmer Biomet Holdings, Inc.'s current ratio of 1.98 is 10% above its 5-year average of 1.80, near the high end of its 5-year range (1.41–1.99).

As of Saturday, June 20, 2026. 1.80% above its 12-month average of 1.94.

ZBH Current Ratio Chart

ZBH Current Ratio
1.98+3.66% 1Y
Zoom

ZBH Average Current Ratio Chart

ZBH Current vs Average Current Ratio Chart

ZBH Current Ratio Metrics

CURRENT RATIO

1.98

CURRENT RATIO AVG TTM

1.94

CURRENT RATIO AVG 3Y

1.85

CURRENT RATIO AVG 5Y

1.80

CURRENT RATIO AVG 10Y

1.91

CURRENT RATIO AVG 15Y

2.60

CURRENT RATIO AVG 20Y

2.70

CURRENT VS TTM AVG

+1.80%

CURRENT VS 3Y AVG

+7.32%

CURRENT VS 5Y AVG

+10.20%

CURRENT VS 10Y AVG

+3.47%

CURRENT VS 15Y AVG

-23.94%

CURRENT VS 20Y AVG

-26.54%

ZBH Competitors' Current Ratio

NAMEMARKET CAPCURRENT RATIOTTM3Y5Y
Zimmer Biomet Holdings, Inc. (ZBH)$17.02B1.981.941.851.80
Hologic, Inc. (HOLX)vs ›$16.97B3.753.723.763.20
DaVita Inc. (DVA)vs ›$13.34B1.291.271.231.26
Medpace Holdings, Inc. (MEDP)vs ›$13.14B0.740.830.680.84
Solventum Corporation (SOLV)vs ›$13.06B1.231.211.401.43
Labcorp Holdings Inc. (LH)vs ›$20.98B1.421.431.381.52
Align Technology, Inc. (ALGN)vs ›$13.04B1.361.291.261.29
The Cooper Companies, Inc. (COO)vs ›$12.85B1.891.901.691.67
United Therapeutics Corporation (UTHR)vs ›$22.78B6.605.926.536.74
Revvity, Inc. (RVTY)vs ›$11.16B1.682.642.372.14

Liquidity Analysis

Current Ratio

1.98

Quick Ratio

1.10

Zimmer Biomet Holdings, Inc. Current Ratio Formula & Definition

Current Ratio = Current Assets / Current Liabilities

The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. Current Ratio FAQ

What is the current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The current ratio for ZBH stock is 1.98.
Is Zimmer Biomet Holdings, Inc.'s current ratio high or low?
Zimmer Biomet Holdings, Inc.'s current ratio of 1.98 is 10% above its 5-year average of 1.80, near the high end of its 5-year range (1.41–1.99).
What is the TTM average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The TTM average current ratio for ZBH stock is 1.94.
What is the 3Y average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 3Y average current ratio for ZBH stock is 1.85.
What is the 5Y average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 5Y average current ratio for ZBH stock is 1.80.
What is the 10Y average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 10Y average current ratio for ZBH stock is 1.91.
What is the 15Y average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 15Y average current ratio for ZBH stock is 2.60.
What is the 20Y average current ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The 20Y average current ratio for ZBH stock is 2.70.

Zimmer Biomet Holdings, Inc. Current Ratio History

DATECURRENT RATIO
2025-12-311.98
2024-12-311.91
2023-12-311.61
2022-12-311.88
2021-12-311.41
2020-12-311.99
2019-12-311.37
2018-12-311.83
2017-12-311.49
2016-12-311.96
2015-12-313.62
2014-12-314.19
2013-12-314.07
2012-12-314.28
2011-12-313.78
2010-12-314.28
2009-12-313.96
2008-12-312.83
2007-12-312.78
2006-12-312.78
2005-12-312.60
2004-12-312.23
2003-12-312.07
2002-12-311.53
2001-12-311.36
2000-12-312.24
1999-12-312.00

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos